Leclerc C, Baker S, Jiang W, Mou B, et al. Treatment With Stereotactic Ablative Radiation Therapy for Patients With up to 5 Oligometastatic Cancer Lesions: Long-Term Outcomes of the Nonrandomized Population-based Phase 2 SABR-5 Clinical Trial. Int J Radiat Oncol Biol Phys 2026;125:330-337.
PMID: 41580164